Pune, Dec. 06, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global blood transfusion diagnostics market is expected to clock US$ 7.95 billion by 2030 and to grow at a CAGR of 6.8% during the forecast period. Owing to the rising incidence of transfusion-associated. This exclusive information is published by Growth Plus Reports in its report titled “Blood Transfusion Diagnostics Market – Global Outlook & Forecast 2022-2030”

Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/blood-transfusion-diagnostics-market/7964

Growth Drivers

Growing blood donation programs are one of the factors propelling the global blood transfusion diagnostics market growth. The need for blood transfusions is being driven by the rising prevalence of chronic and infectious diseases such cancer, hemophilia, renal, liver, severe infection, sickle cell disease, and thrombocytopenia as well as the introduction of technologically advanced goods. An increase in transfusions as a result of trauma, auto accidents, surgeries, and childbirth cases are driving the market.

The global blood transfusion diagnostics market has been analyzed from four perspectives: product, application, end-user, and region.

Excerpts from ‘By Product Segmentation’

Based on product, the global blood transfusion diagnostics market is subdivided into:

• Reagents & Kits

• Instruments

The global blood transfusion diagnostics market is dominated by the reagents & kits segment. This is due to the great demand for the products and their widespread availability. The availability of a wide variety of blood grouping, typing, and donor screening reagents, kits, and tests made by both international and local key players further contributes to the expansion of the global market. This market has grown profitably due to the accessibility of very sophisticated donor screening analyzers. For example, MosaiQ by Quotient is a completely automated platform for donor sample TTI screening and blood grouping.

Excerpts from ‘By End User Segmentation’

The global blood transfusion diagnostics market has been divided into:

• blood banks

• diagnostic laboratories

• hospitals

• others

The global blood transfusion diagnsotics market is dominated by the blood banks segment. This is because blood types and diseases are routinely screened for before transfusion therapy using techniques like blood typing, Rh typing, unexpected RBC antibody screening, and infectious disease screening. Due to hospitals using blood transfusion operations more frequently, the hospital segment is predicted to develop at a higher CAGR throughout the forecast period.

Excerpts from ‘By Region Segmentation’

Based on region, the global blood transfusion diagnostics market has been segmented into:

• North America

• Europe

• Asia Pacific

• Rest of the World

In Asia Pacific, the market for blood transfusion diagnostics is expected to grow at the fastest rate during the forecast period. Increasing awareness about blood donations coupled with the launch of various campaigns in India and Australia is fostering regional growth. However, the declining number of donors in Singapore and South Korea has led to less adoption of transfusion diagnostic tools in Asia Pacific.

Speak to our Analyst to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/blood-transfusion-diagnostics-market/7964

Excerpts from ‘Competitive Landscape’

The prominent players operating in the global blood transfusion diagnostics market are:

• Abbott Laboratories

• Bio-Rad Laboratories

• Quotient Limited

• Immucor Inc.

• Ortho Clinical Diagnostics

• Bag Healthcare Gmbh

• Danaher Corporation

• Diasorin S.P.A

• Hoffman-La-Roche Ltd.

• Biokit S.A. (Werfen)

Table of Content

1. INTRODUCTION

   1. Market Ecosystem

   2. Timeline Under Consideration

      1. Historical Years – 2020

      2. Base Year – 2021

      3. Forecasted Years – 2022 to 2030

   3. Currency Used in the Report

2. RESEARCH METHODOLOGY 

   1. Research Approach

   2. Data Collection Methodology

   3. Data Sources

      1. Secondary Sources

      2. Primary Sources

   4. Market Estimation Approach

      1. Bottom Up

      2. Top Down

   5. Market Forecasting Model

   6. Limitations and Assumptions       

3. PREMIUM INSIGHTS

   1. Current Market Trends (COVID-19 Perspective)

   2. Key Players & Competitive Positioning (2021)

4. MARKET DYNAMICS

   1. Drivers

   2. Restraints/Challenges

   3. Opportunities

5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY PRODUCT

   1. Reagents & Kits

   2. Instruments

   3. Others

6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY APPLICATION

   1. Blood Grouping

   2. Disease Screening

      1. Serological Disease Screening

      2. Molecular Disease Screening

7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY END USER

   1. Blood Banks

   2. Diagnostic Laboratories

   3. Hospitals

   4. Others

TOC Contiued..

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

• Comprehensive quantitative and qualitative insights at segment and sub-segment level

• Covid 19 impact trends and perspective

• Granular insights at global/regional/country level

• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

• Blanket coverage on competitive landscape

• Winning imperatives

• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment

• Pricing Intelligence

• Customer Base Assessment

• Investment & Initiatives Analysis

• 'Business Profile' of Key Players

Purchase this exclusive report now: https://growthplusreports.com/checkout?_token=GqsHTeo872CP3NN6BKUe9RB4q8AvpFOLZeAflI4L&report_id=7964&license=Single

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: enquire@growthplusreports.com Phone no: +91 96545 76783 Web: https://growthplusreports.com/  Follow Us: LinkedIn | Twitter